Avanos Medical, Inc. (NYSE:AVNS) Q4 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Avanos Fourth Quarter 2025 Earnings Conference Call.
Avanos Medical Inc. (AVNS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 3,200,000 | $35,936,000 | +29% | 0.43% |
| 2. | D E Shaw D. E. Shaw | 1,210,456 | $13,593,421 | -7% | 0.01% |
| 3. | Millennium Management Israel Englander | 731,900 | $8,219,237 | -19% | 0% |
| 4. | AQR Capital Management Cliff Asness | 727,696 | $8,172,027 | -21% | 0% |
| 5. | ExodusPoint Capital Michael Gelband | 586,485 | $6,586,227 | +62% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.00 | 40,000 | $439,800.00 | 40,000 | 2025-08-13 | Filing | |
| $10.98 | 20,000 | $219,500.00 | 91,593 | 2025-08-13 | Filing | |
| $19.85 | 500 | $9,925.00 | 50,090 | 2024-03-11 | Filing | |
| $31.67 | 800 | $25,336.00 | 33,900 | 2021-09-15 | Filing | |
| $31.65 | 900 | $28,485.00 | 33,100 | 2021-09-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.02 | 305 | $3,361.10 | 83,860 | 2025-11-18 | Filing | |
| $11.01 | 761 | $8,378.61 | 84,165 | 2025-11-18 | Filing | |
| $11.01 | 100 | $1,100.50 | 84,926 | 2025-11-18 | Filing | |
| $11.00 | 13,834 | $152,174.00 | 85,026 | 2025-11-18 | Filing | |
| $15.25 | 7,000 | $106,778.00 | 82,047 | 2025-03-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 96,411 | $1,350,718 | 0% | |
| 2. | 61,441 | $860,788 | 0.53% | |
| 3. | 36,990 | $518,230 | 0.05% | |
| 4. | 34,500 | $483,345 | 0% | |
| 5. | 26,348 | $371,243 | 0.28% |
News See All
Avanos Medical, Inc. (AVNS): A Bull Case Theory
We came across a bullish thesis on Avanos Medical, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on AVNS.
Avanos Medical, Inc. (NYSE:AVNS) Q3 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Third Quarter 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, November 5, 2025.
Avanos Medical, Inc. (NYSE:AVNS) Q2 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Second Quarter 2025 Earnings Conference Call.
10 Undervalued Medical Device Stocks to Buy Now
According to a report by Mordor Intelligence, the medical device industry is valued at $681.57 billion as of 2025.
Avanos Medical, Inc. (NYSE:AVNS) Q1 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos First Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Tuesday, May 6, 2025.
Avanos Medical (AVNS): Positioned for Growth Under New Leadership
Diamond Hill Capital, an investment management company, released its “Small Cap Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Avanos Medical, Inc. (NYSE:AVNS) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to the Avanos Medical, Inc. fourth quarter 2024 earnings call. At this time, all lines are in listen-only mode.
Avanos (AVNS) Declined due to Reduced Earnings Guidance
Rewey Asset Management, an investment management company, released its “RAM Smid Composite” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Avanos Medical, Inc. (NYSE:AVNS) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call.
Hedge Fund Resource Center